Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

Diagnos Inc

Healthcare CA ADK

0.215CAD
-0.01(4.44%)

Last update at 2026-06-05T19:46:00Z

Day Range

0.210.23
LowHigh

52 Week Range

0.180.42
LowHigh

Fundamentals

  • Previous Close 0.23
  • Market Cap28.03M
  • Volume216500
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-4.48824M
  • Revenue TTM0.07M
  • Revenue Per Share TTM0.001
  • Gross Profit TTM -1.42511M
  • Diluted EPS TTM-0.05

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Income before tax -4.28645M -3.12058M -2.48082M -2.60822M -2.05130M
Minority interest - - - - -
Net income -4.28645M -3.12058M -2.48082M -2.60822M -2.05130M
Selling general administrative 2.88M 1.77M 1.93M 2.24M 1.94M
Selling and marketing expenses - - - - -
Gross profit -0.94356M -0.83794M -0.30677M -0.41830M -0.34753M
Reconciled depreciation 0.13M 0.12M 0.10M 0.11M 0.09M
Ebit - -2.60082M - -2.54980M -2.03750M
Ebitda - -2.47661M -2.10073M -2.44864M -1.93170M
Depreciation and amortization - 0.12M - 0.10M 0.11M
Non operating income net other - - - - -
Operating income -3.81109M -2.60082M -2.22167M -2.55444M -2.01914M
Other operating expenses - 2.77M - 3.10M 2.55M
Interest expense 0.59M 0.55M 0.28M 0.05M 0.03M
Tax provision - - 0.00000M 0.00000M 0.00000M
Interest income 0.05M 0.00689M 0.00777M 0.00538M 0.02M
Net interest income -0.54372M -0.54328M -0.27114M -0.04840M -0.03216M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - 0.00000M - 0.15M 0.30M
Total revenue 0.10M 0.17M 0.49M 0.44M 0.27M
Total operating expenses 3.91M 1.76M 2.71M 2.24M 1.94M
Cost of revenue 1.05M 1.01M 0.79M 0.86M 0.61M
Total other income expense net 0.07M -0.51976M 0.01M 0.10M 0.26M
Discontinued operations - - - - -
Net income from continuing ops -4.28645M -3.12058M -2.48082M -2.60822M -2.05130M
Net income applicable to common shares - - - -2.60822M -2.05130M
Preferred stock and other adjustments - - - - -
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Total assets 3.64M 0.66M 0.82M 1.54M 1.95M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets - 0.02M 0.02M 0.02M 0.03M
Total liab 3.40M 3.72M 2.77M 1.66M 0.82M
Total stockholder equity 0.23M -3.05185M -1.94821M -0.11351M 1.13M
Deferred long term liab - - - - -
Other current liab - 0.19M 0.00671M 0.00667M 0.00417M
Common stock - 37.70M 35.91M 35.68M 34.76M
Capital stock 44.96M 37.70M 35.91M 35.68M 34.76M
Retained earnings -54.93339M -50.64694M -47.52636M -44.99246M -42.38424M
Other liab - - - - -
Good will - - - - -
Other assets - - - - 0.03M
Cash 0.09M 0.22M 0.30M 0.42M 0.36M
Cash and equivalents - - - - -
Total current liabilities 3.12M 1.62M 0.72M 0.66M 0.55M
Current deferred revenue - 0.00839M - - -
Net debt 2.80M 2.97M 1.77M 0.54M -
Short term debt - 1.09M - - -
Short long term debt 2.69M 0.98M 0.17M 0.12M 0.12M
Short long term debt total - 3.19M - - -
Other stockholder equity - - 9.66M 9.20M 8.76M
Property plant equipment - - 0.25M 0.25M 0.33M
Total current assets 3.47M 0.41M 0.57M 1.29M 1.59M
Long term investments - - - 0.00000M 0.03M
Net tangible assets - - - -0.11351M 1.13M
Short term investments 3.15M - 0.00000M 0.50M 1.00M
Net receivables 0.01M 0.17M 0.24M 0.33M 0.18M
Long term debt 0.20M 1.95M 1.90M 0.83M 0.04M
Inventory - - - - -
Accounts payable 0.17M 0.33M 0.29M 0.28M 0.19M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - 9.89M - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total 0.17M 0.26M 0.25M 0.25M 0.36M
Capital lease obligations 0.18M 0.26M 0.24M 0.23M 0.31M
Long term debt total - - - - -
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Investments -3.10000M -0.01402M 0.50M 0.53M 0.30M
Change to liabilities - - -0.00259M 0.12M 0.07M
Total cashflows from investing activities - - 0.47M 0.50M 0.26M
Net borrowings -0.38051M - 1.40M 0.89M -0.20683M
Total cash from financing activities 6.62M 2.35M 1.28M 1.60M 0.88M
Change to operating activities - - 0.00677M 0.00446M 0.10M
Net income -4.28645M -3.12058M -2.48082M -2.60822M -2.05130M
Change in cash -0.13029M -0.07762M -0.12427M 0.06M -0.21105M
Begin period cash flow 0.22M 0.30M 0.42M 0.36M 0.57M
End period cash flow 0.09M 0.22M 0.30M 0.42M 0.36M
Total cash from operating activities -3.63745M -2.40994M -1.88381M -2.03794M -1.35680M
Issuance of capital stock 7.28M 1.64M 0.45M 0.72M 1.11M
Depreciation 0.13M 0.12M 0.10M 0.11M 0.09M
Other cashflows from investing activities - - -0.00105M 0.00454M 0.00511M
Dividends paid 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Change to inventory - - - 0.00263M -0.12031M
Change to account receivables -0.00387M 0.10M 0.08M -0.14224M 0.14M
Sale purchase of stock - - - - -
Other cashflows from financing activities - -0.01402M -0.11835M 0.98M 0.02M
Change to netincome - - 0.39M 0.48M 0.30M
Capital expenditures 0.01M 0.01M 0.02M 0.03M 0.04M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.24142M 0.15M 0.09M -0.01498M 0.31M
Stock based compensation 0.29M 0.18M 0.17M 0.17M 0.43M
Other non cash items 0.29M 0.52M 0.12M 0.03M 0.03M
Free cash flow -3.65117M -2.42080M -1.90804M -2.06895M -1.39898M

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
ADK
Diagnos Inc		 -0.01 4.44% 0.21 - 10.00 411.24 18.74 389.06 -6.1551
NURS
Hydreight Technologies Inc		 -0.165 3.50% 4.55 406.00 25.91 7.85 20.38 7.45 109.02
RHT
Reliq Health Technologies Inc		 - -% 0.21 - - 3.19 5.12 4.07 -10.7759
NXG
NexgenRX Inc.		 0.01 3.53% 0.44 39.00 32.68 1.55 4.64 1.39 7.84
PTEC
Principal Technologies Inc		 -0.18 40.91% 0.26 - - 62.75 355.42 72.08 -0.8075

Reports Covered

Stock Research & News

View All

Profile

DIAGNOS Inc. provides software-based services for healthcare sector in Canada, the United States, Mexico, Chile, and internationally. It offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy, as well as allows eye care specialist to visualize normal retinal landmarks and pathological changes. The company also provides various consulting services in the fields of data analysis and artificial intelligence. DIAGNOS Inc. was founded in 1998 and is headquartered in Brossard, Canada.

Diagnos Inc

7005 Taschereau Boulevard, Brossard, QC, Canada, J4Z 1A7

Key Executives

Name Title Year Born
Mr. Andre Larente CEO, Pres & Exec. Director NA
Mr. Marc-André Massue VP of Fin., CFO & Sec. NA
Mr. Guillermo Moreno Robles VP of Sales NA
Mr. Martin Beland Director of Marketing NA
Mr. Andre Larente CEO, President & Executive Chairman NA
Mr. Marc-André Massue VP of Finance, CFO & Secretary NA
Mr. Yves-Stéphane Couture Chief Operating Officer NA
Mr. Marc-André Massue CA, CPA VP of Finance, CFO & Secretary NA
Mr. Andre Larente CEO, President & Executive Director NA
Dr. Ismail Ben Ayed Chief Artificial Intelligence Scientist NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.